<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.0 20120330//EN" "JATS-archivearticle1.dtd">
<article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="research-article"><?properties open_access?><front><journal-meta><journal-id journal-id-type="nlm-ta">J Res Med Sci</journal-id><journal-id journal-id-type="publisher-id">JRMS</journal-id><journal-title-group><journal-title>Journal of Research in Medical Sciences : The Official Journal of Isfahan University of Medical Sciences</journal-title></journal-title-group><issn pub-type="ppub">1735-1995</issn><issn pub-type="epub">1735-7136</issn><publisher><publisher-name>Medknow Publications &#x00026; Media Pvt Ltd</publisher-name><publisher-loc>India</publisher-loc></publisher></journal-meta><article-meta><article-id pub-id-type="pmid">22279454</article-id><article-id pub-id-type="pmc">3263099</article-id><article-id pub-id-type="publisher-id">JRMS-16-878</article-id><article-categories><subj-group subj-group-type="heading"><subject>Original Article</subject></subj-group></article-categories><title-group><article-title>The effect of Omega-3 fatty acids on serum paraoxonase activity, vitamins A, E, and C in type 2 diabetic patients</article-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Kouchak</surname><given-names>Anis</given-names></name><xref ref-type="aff" rid="aff1">1</xref></contrib><contrib contrib-type="author"><name><surname>Djalali</surname><given-names>Mahmoud</given-names></name><xref ref-type="aff" rid="aff1">1</xref></contrib><contrib contrib-type="author"><name><surname>Eshraghian</surname><given-names>Mohamadreza</given-names></name><xref ref-type="aff" rid="aff2">2</xref></contrib><contrib contrib-type="author"><name><surname>Saedisomeolia</surname><given-names>Ahmad</given-names></name><xref ref-type="aff" rid="aff1">1</xref></contrib><contrib contrib-type="author"><name><surname>Djazayery</surname><given-names>Abolghassem</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="corresp" rid="cor1"/></contrib><contrib contrib-type="author"><name><surname>Hajianfar</surname><given-names>Hossein</given-names></name><xref ref-type="aff" rid="aff1">1</xref></contrib></contrib-group><aff id="aff1"><label>1-</label> Department of Nutrition and Biochemistry, School of Public Health, Tehran University of Medical Sciences, Tehran, Iran.</aff><aff id="aff2"><label>2-</label> Department of Biostatistics, School of Public Health, Tehran University of Medical Sciences, Tehran, Iran.</aff><author-notes><corresp id="cor1">
Corresponding Author: Abolghassem Djazayery, E-mail: <email xlink:href="jazaiers@tums.ac.ir">jazaiers@tums.ac.ir</email></corresp></author-notes><pub-date pub-type="ppub"><month>7</month><year>2011</year></pub-date><volume>16</volume><issue>7</issue><fpage>878</fpage><lpage>884</lpage><history><date date-type="received"><day>13</day><month>11</month><year>2010</year></date><date date-type="accepted"><day>19</day><month>5</month><year>2011</year></date></history><permissions><copyright-statement>Copyright: &#x000a9; Journal of Research in Medical Sciences</copyright-statement><copyright-year>2011</copyright-year><license license-type="open-access" xlink:href="http://creativecommons.org/licenses/by-nc-sa/3.0"><license-p>This is an open-access article distributed under the terms of the Creative Commons Attribution-Noncommercial-Share Alike 3.0 Unported, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.</license-p></license></permissions><abstract><sec id="st1"><title>BACKGROUND:</title><p>Diabetes mellitus is a heterogeneous metabolic disorder characterized by hyperglycemia. Studies showed paraoxonase activity, and vitamin C and A levels are decreased in diabetes. The effect of omega-3 fatty acids on serum paraoxonase activity and vitamins A, E, C in patients with type 2 diabetes is not fully understood. This study aimed to determine the effect of omega-3 fatty acids on paraoxonase activity, vitamins C, A and E levels in type 2 diabetic patients.</p></sec><sec id="st2"><title>METHODS:</title><p>In a double-blind, placebo controlled trial, 80 type 2 diabetic patients were randomly enrolled into the study. Study subjects received daily 2714 mg of omega-3 fatty acids or placebo for 8 weeks. Ten milliliter fasting blood was collected before and after treatments. Serum paraoxonase activity and vitamin C levels were measured by spectrophotometry. Vitamin A and vitamin E were measured using high performance liquid chromatography. Nutrient intake was estimated using 24-hours dietary recall questionnaire (for 2 days) before and after treatments. Dietary data were analyzed using FPII. To compare the means of variables between the two groups, independent t-test was employed. Differences between variables before and after interventions were calculated using paired t-test.</p></sec><sec id="st3"><title>RESULTS:</title><p>Serum levels of paraoxonase activity were significantly increased after omega-3 intake (126.47 IU/ml <italic>vs</italic>. 180.13 IU/ml). However, omega-3 intake caused no significant change in serum vitamin A, C, and E.</p></sec><sec id="st4"><title>CONCLUSIONS:</title><p>Supplementation of omega-3 fatty acids was found to increase paraoxonase activity in diabetic patients.</p></sec></abstract><kwd-group><title>KEYWORDS:</title><kwd>Paraoxonase</kwd><kwd>Diabetes mellitus</kwd><kwd>Vitamin C</kwd><kwd>Vitamin A</kwd><kwd>Vitamin E</kwd></kwd-group></article-meta></front><body><p>Diabetes is a complex metabolic disease characterized by high blood glucose level.<xref ref-type="bibr" rid="ref1">1</xref> Its macrovascular complications include atherosclerosis, and its microvascular complications include damage to the kidney, nerves and eyes.<xref ref-type="bibr" rid="ref2">2</xref> Oxidative stress is increased in diabetes,<xref ref-type="bibr" rid="ref3">3</xref> therefore, it is considered as a cause of development of atherosclerosis.<xref ref-type="bibr" rid="ref4">4</xref> In diabetic patients, atherosclerosis is one of the most important causes of mortality.<xref ref-type="bibr" rid="ref5">5</xref> Human paraoxonase (PON-1) which is an antioxidant (via scavenging of free radicals),<xref ref-type="bibr" rid="ref6">6</xref> is synthesized in the liver and secreted into blood, where it is associated with high density lipoprotein (HDL) levels,<xref ref-type="bibr" rid="ref7">7</xref> and serum paraoxonase levels are inversely related to the risk of cardiovascular disease.<xref ref-type="bibr" rid="ref8">8</xref><xref ref-type="bibr" rid="ref9">9</xref> Some studies found that PON-1 activity is decreased in cardiovascular and diabetes mellitus.<xref ref-type="bibr" rid="ref10">10</xref><xref ref-type="bibr" rid="ref11">11</xref></p><p>Vitamin C is an important antioxidant in human,<xref ref-type="bibr" rid="ref12">12</xref><xref ref-type="bibr" rid="ref13">13</xref> however, several studies showed vitamin C level in diabetic patients is decreased.<xref ref-type="bibr" rid="ref14">14</xref><xref ref-type="bibr" rid="ref15">15</xref> Vitamin A is a hydrophobic antioxidant<xref ref-type="bibr" rid="ref16">16</xref><xref ref-type="bibr" rid="ref17">17</xref> which is decreased in diabetes causes retinopathy.<xref ref-type="bibr" rid="ref18">18</xref> Also, vitamin E is a hydrophobic antioxidant which is found in membranes as well as lipoproteins and can afford primary as well as secondary stage protection against ROS activity.<xref ref-type="bibr" rid="ref12">12</xref><xref ref-type="bibr" rid="ref19">19</xref> Many studies showed the association between intake of omega-3 fatty acids and decreased risk of coronary heart disease<xref ref-type="bibr" rid="ref20">20</xref><xref ref-type="bibr" rid="ref21">21</xref> and its mortality.<xref ref-type="bibr" rid="ref21">21</xref> Studies with evaluation of the metabolic effect of omega-3 fatty acids on serum vitamins A, E, C in patients with type 2 diabetes are rare in literature. In addition, the metabolic effect of omega-3 fatty acids in patients with type 2 diabetes is not fully clear. There is also no evidence about the effect of omega-3 fatty acids in patients with type 2 diabetes in Iranian population. The aim of this study was to determine the effect of omega-3 fatty acids on paraoxonase activity, as well as the levels of vitamin A, C and E in Iranian diabetic type 2 patients.</p><sec sec-type="methods" id="sec1-1"><title>Methods</title><sec id="sec2-1"><title/><sec id="sec3-1"><title>Study design</title><p>The present study was a randomized double blind placebo-controlled study financially supported by Tehran University of Medical Science (research project number: 2296). Study subjects included 80 type 2 diabetic patients (aged 45-80 years) with at least 2 years of diagnosed diabetes since onset of the condition. The subjects had a written consent to enroll into the study from Iranian Diabetes Association, Tehran, Iran using written announcement. They were divided randomly into two groups (experiment and control, n = 41 and n = 40, respectively) using computer's random numbers. Subjects had their routine medication regimens. Patients did not take omega-3 fatty acid supplements and/or medications interacting with lipid profile, did not have hepatic or renal disease, and had no history of cancer or myocardial infarction. Each patient received 3 capsules per day for 8 weeks. The dose of the supplements was chosen from other studies<xref ref-type="bibr" rid="ref22">22</xref>. The supplement was obtained from PBL Company, US. Omega-3 fatty acid dose was 2714 mg (EPA= 1548 mg, DHA= 828 mg and 338 mg of other omega-3 fatty acids) via 3 gel capsules. Placebo consisted of 3 capsules containing 2100 mg sunflower oil (12% SFA, 65% linoleic acid, and 23% MUFA). Placebo capsules looked identical and were prepared for this study by Zakaria Inc., Tehran, Iran.</p></sec><sec id="sec3-2"><title>Data collection</title><p>Anthropometric data, medical and drug history were obtained via face-to-face interviews. Ten milliliter blood was collected from each patient after 12-14 hours overnight fasting, before taking oral hypoglycemia drugs, between 8-10 a.m., at the beginning and at the end of 8 weeks. Fasting blood sugar was measured. Paraoxonase (PON-1) activity and vitamin C were measured by spectrophotometry; and vitamin E and A were measured using HPLC. Daily nutrient intakes were estimated using 24-hour dietary recall questionnaires at the beginning and at the end of the study for 2 days. Dietary data were analyzed using Food Processor version 2 software. The patients were asked not to change their usual diets, activity and medications throughout the study.</p></sec><sec id="sec3-3"><title>Statistical analysis</title><p>Differences between the two groups of supplemented and control groups were calculated using independent t-test. Differences between variables before and after interventions were calculated using paired t-test. Statistical analyses were performed using SPSS 11 (compatible with Microsoft Windows). The results are expressed as mean &#x000b1; SD (standard deviation). For statistical evaluations, P value of less than 0.05 was considered as a significant change.</p></sec></sec></sec><sec id="sec1-2"><title>Results</title><p>The clinical and demographic characteristics of subjects are shown in <xref ref-type="table" rid="T1">Table 1</xref>. Participants in case or control groups had equal age, sex, BMI, glucose and duration of diabetes at the beginning of the study (P &#x0003e; 0.05). As shown in <xref ref-type="table" rid="T2">Table 2</xref>, energy and nutrient intake before and after intervention were also equal. <xref ref-type="table" rid="T3">Table 3</xref> shows that there was no significant difference in serum paraoxonase activity between the two groups before and after intervention, but after 8 weeks of omega-3 supplementation, serum paraoxonase activity was increased compared to its activity before treatment (P=0.002). <xref ref-type="table" rid="T4">Table 4</xref> presents the serum concentration of vitamins (A, E and C) in subjects before and after supplementation. At the beginning of the study, 2 groups were similar by the means of vitamins level. Following 2 months of supplementation, serum levels of vitamins A, E, C were not significantly changed in the case group.</p><table-wrap id="T1" position="float"><label>Table 1</label><caption><p>Demographic and clinical characteristic of the study groups</p></caption><graphic xlink:href="JRMS-16-878-g001"/></table-wrap><table-wrap id="T2" position="float"><label>Table 2</label><caption><p>Comparison of dietary intake of macro- and micro-nutrients between two groups of study</p></caption><graphic xlink:href="JRMS-16-878-g002"/></table-wrap><table-wrap id="T3" position="float"><label>Table 3</label><caption><p>Paraoxonase (arylesterase) (IU/mL) activity before and after 2 months omega-3 supplementation in type 2 diabetic patients</p></caption><graphic xlink:href="JRMS-16-878-g003"/></table-wrap><table-wrap id="T4" position="float"><label>Table 4</label><caption><p>Levels of vitamin A, E (&#x003bc;mol/L) and vitamin C (mg/dl) before and after 2 months omega-3 supplementation in type 2 diabetic patients</p></caption><graphic xlink:href="JRMS-16-878-g004"/></table-wrap><p><xref ref-type="table" rid="T4">Table 4</xref> presents the serum concentration of vitamins (A, E and C) in subjects before and after supplementation. At the beginning of the study, two groups were similar by the means of vitamin levels. Following 2 months of supplementation, serum levels of vitamins A, E, C were not significantly changed in the case group.</p></sec><sec id="sec1-3"><title>Discussion</title><p>It is believed that oxidative stress plays an important role in the pathogenesis of type II diabetes.<xref ref-type="bibr" rid="ref23">23</xref> Many studies on diabetes mellitus have showed that free radicals can cause chronic complications such as cardiovascular disease.<xref ref-type="bibr" rid="ref24">24</xref> Paraoxonase protects low density lipoprotein (LDL) and high density lipoprotein (HDL) against oxidative modification.<xref ref-type="bibr" rid="ref25">25</xref> It is believed that the oxidation of LDL is the first stage of development of atherosclerosis.<xref ref-type="bibr" rid="ref26">26</xref> Mackness and Karabina found that paraoxonase activity decreases in cardiovascular disease as well as in diabetes mellitus.<xref ref-type="bibr" rid="ref10">10</xref><xref ref-type="bibr" rid="ref11">11</xref> Omega-3 fatty acids are a class of polyunsaturated fatty acids that found in fish and fish oils.<xref ref-type="bibr" rid="ref27">27</xref> Omega-3 fatty acids from seafood and plant sources can reduce coronary heart disease.<xref ref-type="bibr" rid="ref28">28</xref> Our previous studies showed that omega-3 PUFA can decrease the inflammation in a cell culture model.<xref ref-type="bibr" rid="ref29">29</xref> The possible mechanism of anti-inflammatory effect of omega-3 PUFA is the decreased levels of arachidonic acid inflammatory pathway in the cells.<xref ref-type="bibr" rid="ref30">30</xref> However, it is believed that these fatty acids has no antioxidant activity and increase the utilization of the antioxidants.<xref ref-type="bibr" rid="ref30">30</xref> In our study, it is found that paraoxonase activity increased following omega-3 supplements. The changes in paraoxonase activity were observed after 8 weeks of supplementation of omega-3 by Calabresi.<xref ref-type="bibr" rid="ref31">31</xref> In other studies, it has been found that plasma concentration of HDL-bound antioxidant paraoxonase enzyme increased by 10% after omega-3 supplementation<xref ref-type="bibr" rid="ref31">31</xref> which is in the same track of our study.</p><p>Increased oxidative stress in diabetes could contribute to depletion of antioxidants.<xref ref-type="bibr" rid="ref32">32</xref> Several studies showed decreased basal vitamin C levels (a potent water phase antioxidant) in diabetic patients.<xref ref-type="bibr" rid="ref33">33</xref><xref ref-type="bibr" rid="ref34">34</xref> There are conflicting reports regarding plasma vitamin concentrations in diabetes mellitus. Merzouk found no alteration in the levels of serum vitamin C, whereas the levels of vitamin A and E were lower in type I and type II diabetes mellitus patients with or without complications than in control subjects.<xref ref-type="bibr" rid="ref35">35</xref> Studies also reported that plasma vitamin C and E in type II diabetic patients were not significantly different from those in control groups, while vitamin A levels were significantly lower.<xref ref-type="bibr" rid="ref36">36</xref><xref ref-type="bibr" rid="ref37">37</xref> On the other hand, Sundaram reported low levels of vitamin E and C in diabetic patients.<xref ref-type="bibr" rid="ref38">38</xref> Basu showed that the concentration of serum vitamin A and its binding protein, RBP, were lower in patients with diabetes than in normal control subjects.<xref ref-type="bibr" rid="ref39">39</xref> The present study demonstrated no significant change in vitamin A, C and E after consumption of omega-3 fatty acids. Zhou demonstrated that &#x003b1;-linolenic acid deficiency decreased DHA and elevated Osbond acid (OA) levels in tissue membranes, and dietary vitamin A deficiency had an important effect on membrane DHA and OA in rat tissues.<xref ref-type="bibr" rid="ref40">40</xref><xref ref-type="bibr" rid="ref41">41</xref> However, the effect of omega-3 on vitamin A, C and E in diabetic patients has not been studied recently.</p></sec><sec id="sec1-4"><title>Conclusion</title><p>The present study demonstrated for the first time, that there was no significant change in vitamin A, C and E after consumption of omega-3 fatty acids. We concluded that omega-3 fatty acid supplementation (3 g/per day) in the form of capsules can increase paraoxonase activity in diabetic patients. The metabolic effect of omega-3 fatty acid in diabetic patients is less studied.</p></sec><sec id="sec1-5"><title>Authors&#x02019; Contributions</title><p>All the authors have carried out the study, participated in the design of the study and acquisition of data performed the statistical analysis and wrote the manuscript. All authors read and approved the final manuscript.</p></sec></body><back><fn-group><fn fn-type="conflict"><p><bold>Conflict of Interests</bold> Authors have no conflict of interests.</p></fn></fn-group><ref-list><ref id="ref1"><label>1</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Canepa</surname><given-names>ET</given-names></name><name><surname>Llambias</surname><given-names>EB</given-names></name><name><surname>Grinstein</surname><given-names>M</given-names></name></person-group><article-title>Studies on regulatory mechanisms of heme biosynthesis in hepatocytes from normal and experimental-diabetic rats. Role of insulin</article-title><source>Biochem Cell Biol</source><year>1990</year><volume>68</volume><issue>6</issue><fpage>914</fpage><lpage>21</lpage><pub-id pub-id-type="pmid">2168718</pub-id></element-citation></ref><ref id="ref2"><label>2</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Reusch</surname><given-names>JE</given-names></name></person-group><article-title>Diabetes, microvascular complications, and cardiovascular complications: what is it about glucose?</article-title><source>J Clin Invest</source><year>2003</year><volume>112</volume><issue>7</issue><fpage>986</fpage><lpage>8</lpage><pub-id pub-id-type="pmid">14523035</pub-id></element-citation></ref><ref id="ref3"><label>3</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Evans</surname><given-names>M</given-names></name><name><surname>Anderson</surname><given-names>RA</given-names></name><name><surname>Smith</surname><given-names>JC</given-names></name><name><surname>Khan</surname><given-names>N</given-names></name><name><surname>Graham</surname><given-names>JM</given-names></name><name><surname>Thomas</surname><given-names>AW</given-names></name><etal/></person-group><article-title>Effects of insulin lispro and chronic vitamin C therapy on postprandial lipaemia, oxidative stress and endothelial function in patients with type 2 diabetes mellitus</article-title><source>Eur J Clin Invest</source><year>2003</year><volume>33</volume><issue>3</issue><fpage>231</fpage><lpage>8</lpage><pub-id pub-id-type="pmid">12641541</pub-id></element-citation></ref><ref id="ref4"><label>4</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Neyestani</surname><given-names>TR</given-names></name><name><surname>Shariatzadeh</surname><given-names>N</given-names></name><name><surname>Gharavi</surname><given-names>A</given-names></name><name><surname>Kalayi</surname><given-names>A</given-names></name><name><surname>Khalaji</surname><given-names>N</given-names></name></person-group><article-title>Physiological dose of lycopene suppressed oxidative stress and enhanced serum levels of immunoglobulin M in patients with Type 2 diabetes mellitus: a possible role in the prevention of long-term complications</article-title><source>J Endocrinol Invest</source><year>2007</year><volume>30</volume><issue>10</issue><fpage>833</fpage><lpage>8</lpage><pub-id pub-id-type="pmid">18075285</pub-id></element-citation></ref><ref id="ref5"><label>5</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yamagishi</surname><given-names>K</given-names></name><name><surname>Iso</surname><given-names>H</given-names></name><name><surname>Date</surname><given-names>C</given-names></name><name><surname>Fukui</surname><given-names>M</given-names></name><name><surname>Wakai</surname><given-names>K</given-names></name><name><surname>Kikuchi</surname><given-names>S</given-names></name><etal/></person-group><article-title>Fish, omega-3 polyunsaturated fatty acids, and mortality from cardiovascular diseases in a nationwide community-based cohort of Japanese men and women the JACC (Japan Collaborative Cohort Study for Evaluation of Cancer Risk) Study</article-title><source>J Am Coll Cardiol</source><year>2008</year><volume>52</volume><issue>12</issue><fpage>988</fpage><lpage>96</lpage><pub-id pub-id-type="pmid">18786479</pub-id></element-citation></ref><ref id="ref6"><label>6</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Valiyaveettil</surname><given-names>M</given-names></name><name><surname>Alamneh</surname><given-names>Y</given-names></name><name><surname>Biggemann</surname><given-names>L</given-names></name><name><surname>Soojhawon</surname><given-names>I</given-names></name><name><surname>Farag</surname><given-names>HA</given-names></name><name><surname>Agrawal</surname><given-names>P</given-names></name><etal/></person-group><article-title>In vitro efficacy of paraoxonase 1 from multiple sources against various organophosphates</article-title><source>Toxicol In Vitro</source><year>2011</year><volume>25</volume><issue>4</issue><fpage>905</fpage><lpage>13</lpage><pub-id pub-id-type="pmid">21382471</pub-id></element-citation></ref><ref id="ref7"><label>7</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hassett</surname><given-names>C</given-names></name><name><surname>Richter</surname><given-names>RJ</given-names></name><name><surname>Humbert</surname><given-names>R</given-names></name><name><surname>Chapline</surname><given-names>C</given-names></name><name><surname>Crabb</surname><given-names>JW</given-names></name><name><surname>Omiecinski</surname><given-names>CJ</given-names></name><etal/></person-group><article-title>Characterization of cDNA clones encoding rabbit and human serum paraoxonase: the mature protein retains its signal sequence</article-title><source>Biochemistry</source><year>1991</year><volume>30</volume><issue>42</issue><fpage>10141</fpage><lpage>9</lpage><pub-id pub-id-type="pmid">1657140</pub-id></element-citation></ref><ref id="ref8"><label>8</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Costa</surname><given-names>LG</given-names></name><name><surname>Cole</surname><given-names>TB</given-names></name><name><surname>Jarvik</surname><given-names>GP</given-names></name><name><surname>Furlong</surname><given-names>CE</given-names></name></person-group><article-title>Functional genomic of the paraoxonase (PON1) polymorphisms: effects on pesticide sensitivity, cardiovascular disease, and drug metabolism</article-title><source>Annu Rev Med</source><year>2003</year><volume>54</volume><fpage>371</fpage><lpage>92</lpage><pub-id pub-id-type="pmid">12525679</pub-id></element-citation></ref><ref id="ref9"><label>9</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Durrington</surname><given-names>PN</given-names></name><name><surname>Mackness</surname><given-names>B</given-names></name><name><surname>Mackness</surname><given-names>MI</given-names></name></person-group><article-title>Paraoxonase and atherosclerosis</article-title><source>Arterioscler Thromb Vasc Biol</source><year>2001</year><volume>21(4)</volume><fpage>473</fpage><lpage>80</lpage><pub-id pub-id-type="pmid">11304460</pub-id></element-citation></ref><ref id="ref10"><label>10</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Karabina</surname><given-names>SA</given-names></name><name><surname>Lehner</surname><given-names>AN</given-names></name><name><surname>Frank</surname><given-names>E</given-names></name><name><surname>Parthasarathy</surname><given-names>S</given-names></name><name><surname>Santanam</surname><given-names>N</given-names></name></person-group><article-title>Oxidative inactivation of paraoxonase--implications in diabetes mellitus and atherosclerosis</article-title><source>Biochim Biophys Acta</source><year>2005</year><volume>1725</volume><issue>2</issue><fpage>213</fpage><lpage>21</lpage><pub-id pub-id-type="pmid">16112460</pub-id></element-citation></ref><ref id="ref11"><label>11</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mackness</surname><given-names>MI</given-names></name><name><surname>Durrington</surname><given-names>PN</given-names></name><name><surname>Mackness</surname><given-names>B</given-names></name></person-group><article-title>The role of paraoxonase 1 activity in cardiovascular disease: potential for therapeutic intervention</article-title><source>Am J Cardiovasc Drugs</source><year>2004</year><volume>4</volume><issue>4</issue><fpage>211</fpage><lpage>7</lpage><pub-id pub-id-type="pmid">15285696</pub-id></element-citation></ref><ref id="ref12"><label>12</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lai</surname><given-names>MH</given-names></name></person-group><article-title>Antioxidant effects and insulin resistance improvement of chromium combined with vitamin C and e supplementation for type 2 diabetes mellitus</article-title><source>J Clin Biochem Nutr</source><year>2008</year><volume>43</volume><issue>3</issue><fpage>191</fpage><lpage>8</lpage><pub-id pub-id-type="pmid">19015754</pub-id></element-citation></ref><ref id="ref13"><label>13</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Riccioni</surname><given-names>G</given-names></name><name><surname>Bucciarelli</surname><given-names>T</given-names></name><name><surname>Mancini</surname><given-names>B</given-names></name><name><surname>Di</surname><given-names>IC</given-names></name><name><surname>Capra</surname><given-names>V</given-names></name><name><surname>D&#x02019;Orazio</surname><given-names>N</given-names></name></person-group><article-title>The role of the antioxidant vitamin supplementation in the prevention of cardiovascular diseases</article-title><source>Expert Opin Investig Drugs</source><year>2007</year><volume>16</volume><issue>1</issue><fpage>25</fpage><lpage>32</lpage></element-citation></ref><ref id="ref14"><label>14</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dorchy</surname><given-names>H</given-names></name></person-group><article-title>Lower plasma vitamin C levels in young type I diabetic patients with microalbuminuria</article-title><source>J Diabetes Complications</source><year>1999</year><volume>13</volume><issue>2</issue><fpage>119</fpage><pub-id pub-id-type="pmid">10432177</pub-id></element-citation></ref><ref id="ref15"><label>15</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Takahashi</surname><given-names>N</given-names></name><name><surname>Morimoto</surname><given-names>S</given-names></name><name><surname>Okigaki</surname><given-names>M</given-names></name><name><surname>Seo</surname><given-names>M</given-names></name><name><surname>Someya</surname><given-names>K</given-names></name><name><surname>Morita</surname><given-names>T</given-names></name><etal/></person-group><article-title>Decreased plasma level of vitamin C in chronic kidney disease: comparison between diabetic and non-diabetic patients</article-title><source>Nephrol Dial Transplant</source><year>2011</year><volume>26</volume><issue>4</issue><fpage>1252</fpage><lpage>7</lpage><pub-id pub-id-type="pmid">20817670</pub-id></element-citation></ref><ref id="ref16"><label>16</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dobrucki</surname><given-names>R</given-names></name><name><surname>Radomska</surname><given-names>A</given-names></name></person-group><article-title>Retinol palmitate as a model substance to test antioxidant properties in vitro on the example of captopril</article-title><source>Pharmazie</source><year>2002</year><volume>57</volume><issue>9</issue><fpage>635</fpage><lpage>7</lpage><pub-id pub-id-type="pmid">12369453</pub-id></element-citation></ref><ref id="ref17"><label>17</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tesoriere</surname><given-names>L</given-names></name><name><surname>D&#x02019;Arpa</surname><given-names>D</given-names></name><name><surname>Re</surname><given-names>R</given-names></name><name><surname>Livrea</surname><given-names>MA</given-names></name></person-group><article-title>Antioxidant reactions of all-trans retinol in phospholipid bilayers: effect of oxygen partial pressure, radical fluxes, and retinol concentration</article-title><source>Arch Biochem Biophys</source><year>1997</year><volume>343</volume><issue>1</issue><fpage>13</fpage><lpage>8</lpage><pub-id pub-id-type="pmid">9210641</pub-id></element-citation></ref><ref id="ref18"><label>18</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Johnson</surname><given-names>AT</given-names></name><name><surname>Kretzer</surname><given-names>FL</given-names></name></person-group><article-title>Interstitial retinol binding protein in the developing human retina: a proposed explanation for vitamin E suppression of retinopathy of prematurity</article-title><source>Prog Clin Biol Res</source><year>1985</year><volume>190</volume><fpage>251</fpage><lpage>77</lpage><pub-id pub-id-type="pmid">3840263</pub-id></element-citation></ref><ref id="ref19"><label>19</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Shirpoor</surname><given-names>A</given-names></name><name><surname>Ilkhanizadeh</surname><given-names>B</given-names></name><name><surname>Saadatian</surname><given-names>R</given-names></name><name><surname>Darvari</surname><given-names>BS</given-names></name><name><surname>Behtaj</surname><given-names>F</given-names></name><name><surname>Karimipour</surname><given-names>M</given-names></name><etal/></person-group><article-title>Effect of vitamin E on diabetes-induced changes in small intestine and plasma antioxidant capacity in rat</article-title><source>J Physiol Biochem</source><year>2006</year><volume>62</volume><issue>3</issue><fpage>171</fpage><lpage>7</lpage><pub-id pub-id-type="pmid">17451158</pub-id></element-citation></ref><ref id="ref20"><label>20</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bucher</surname><given-names>HC</given-names></name><name><surname>Hengstler</surname><given-names>P</given-names></name><name><surname>Schindler</surname><given-names>C</given-names></name><name><surname>Meier</surname><given-names>G</given-names></name></person-group><article-title>N-3 polyunsaturated fatty acids in coronary heart disease: a meta-analysis of randomized controlled trials</article-title><source>Am J Med</source><year>2002</year><volume>112</volume><issue>4</issue><fpage>298</fpage><lpage>304</lpage><pub-id pub-id-type="pmid">11893369</pub-id></element-citation></ref><ref id="ref21"><label>21</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hu</surname><given-names>FB</given-names></name><name><surname>Cho</surname><given-names>E</given-names></name><name><surname>Rexrode</surname><given-names>KM</given-names></name><name><surname>Albert</surname><given-names>CM</given-names></name><name><surname>Manson</surname><given-names>JE</given-names></name></person-group><article-title>Fish and long-chain omega-3 fatty acid intake and risk of coronary heart disease and total mortality in diabetic women</article-title><source>Circulation</source><year>2003</year><volume>107</volume><issue>14</issue><fpage>1852</fpage><lpage>7</lpage><pub-id pub-id-type="pmid">12668520</pub-id></element-citation></ref><ref id="ref22"><label>22</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tanaka</surname><given-names>N</given-names></name><name><surname>Sano</surname><given-names>K</given-names></name><name><surname>Horiuchi</surname><given-names>A</given-names></name><name><surname>Tanaka</surname><given-names>E</given-names></name><name><surname>Kiyosawa</surname><given-names>K</given-names></name><name><surname>Aoyama</surname><given-names>T</given-names></name></person-group><article-title>Highly purified eicosapentaenoic acid treatment improves nonalcoholic steatohepatitis</article-title><source>J Clin Gastroenterol</source><year>2008</year><volume>42</volume><issue>4</issue><fpage>413</fpage><lpage>8</lpage><pub-id pub-id-type="pmid">18277895</pub-id></element-citation></ref><ref id="ref23"><label>23</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Carmeli</surname><given-names>E</given-names></name><name><surname>Coleman</surname><given-names>R</given-names></name><name><surname>Berner</surname><given-names>YN</given-names></name></person-group><article-title>Activities of antioxidant scavenger enzymes (superoxide dismutase and glutathione peroxidase) in erythrocytes in adult women with and without type II diabetes</article-title><source>Exp Diabesity Res</source><year>2004</year><volume>5</volume><issue>2</issue><fpage>171</fpage><lpage>5</lpage><pub-id pub-id-type="pmid">15203888</pub-id></element-citation></ref><ref id="ref24"><label>24</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Song</surname><given-names>SH</given-names></name><name><surname>Hardisty</surname><given-names>CA</given-names></name></person-group><article-title>Early-onset Type 2 diabetes mellitus: an increasing phenomenon of elevated cardiovascular risk</article-title><source>Expert Rev Cardiovasc Ther</source><year>2008</year><volume>6</volume><issue>3</issue><fpage>315</fpage><lpage>22</lpage><pub-id pub-id-type="pmid">18327993</pub-id></element-citation></ref><ref id="ref25"><label>25</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Shih</surname><given-names>DM</given-names></name><name><surname>Xia</surname><given-names>YR</given-names></name><name><surname>Wang</surname><given-names>XP</given-names></name><name><surname>Miller</surname><given-names>E</given-names></name><name><surname>Castellani</surname><given-names>LW</given-names></name><name><surname>Subbanagounder</surname><given-names>G</given-names></name><etal/></person-group><article-title>Combined serum paraoxonase knockout/apolipoprotein E knockout mice exhibit increased lipoprotein oxidation and atherosclerosis</article-title><source>J Biol Chem</source><year>2000</year><volume>275</volume><issue>23</issue><fpage>17527</fpage><lpage>35</lpage><pub-id pub-id-type="pmid">10748217</pub-id></element-citation></ref><ref id="ref26"><label>26</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Berliner</surname><given-names>JA</given-names></name><name><surname>Navab</surname><given-names>M</given-names></name><name><surname>Fogelman</surname><given-names>AM</given-names></name><name><surname>Frank</surname><given-names>JS</given-names></name><name><surname>Demer</surname><given-names>LL</given-names></name><name><surname>Edwards</surname><given-names>PA</given-names></name><etal/></person-group><article-title>Atherosclerosis: basic mechanisms. Oxidation, inflammation, and genetics</article-title><source>Circulation</source><year>1995</year><volume>91</volume><issue>9</issue><fpage>2488</fpage><lpage>96</lpage><pub-id pub-id-type="pmid">7729036</pub-id></element-citation></ref><ref id="ref27"><label>27</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Calder</surname><given-names>PC</given-names></name><name><surname>Yaqoob</surname><given-names>P</given-names></name></person-group><article-title>Omega-3 (n-3) fatty acids, cardiovascular disease and stability of atherosclerotic plaques</article-title><source>Cell Mol Biol (Noisy -le -grand)</source><year>2010</year><volume>56</volume><issue>1</issue><fpage>28</fpage><lpage>37</lpage><pub-id pub-id-type="pmid">20196967</pub-id></element-citation></ref><ref id="ref28"><label>28</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mozaffarian</surname><given-names>D</given-names></name><name><surname>Ascherio</surname><given-names>A</given-names></name><name><surname>Hu</surname><given-names>FB</given-names></name><name><surname>Stampfer</surname><given-names>MJ</given-names></name><name><surname>Willett</surname><given-names>WC</given-names></name><name><surname>Siscovick</surname><given-names>DS</given-names></name><etal/></person-group><article-title>Interplay between different polyunsaturated fatty acids and risk of coronary heart disease in men</article-title><source>Circulation</source><year>2005</year><volume>111</volume><issue>2</issue><fpage>157</fpage><lpage>64</lpage><pub-id pub-id-type="pmid">15630029</pub-id></element-citation></ref><ref id="ref29"><label>29</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Saedisomeolia</surname><given-names>A</given-names></name><name><surname>Wood</surname><given-names>LG</given-names></name><name><surname>Garg</surname><given-names>ML</given-names></name><name><surname>Gibson</surname><given-names>PG</given-names></name><name><surname>Wark</surname><given-names>PA</given-names></name></person-group><article-title>Anti-inflammatory effects of long-chain n-3 PUFA in rhinovirus-infected cultured airway epithelial cells</article-title><source>Br J Nutr</source><year>2009</year><volume>101</volume><issue>4</issue><fpage>533</fpage><lpage>40</lpage><pub-id pub-id-type="pmid">18631417</pub-id></element-citation></ref><ref id="ref30"><label>30</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Saedisomeolia</surname><given-names>A</given-names></name><name><surname>Wood</surname><given-names>LG</given-names></name><name><surname>Garg</surname><given-names>ML</given-names></name><name><surname>Gibson</surname><given-names>PG</given-names></name><name><surname>Wark</surname><given-names>PA</given-names></name></person-group><article-title>Supplementation of long chain N-3 polyunsaturated fatty acidsincrease the utilization oflycopene in cultured airway epithelial cells</article-title><source>Journal of Food Lipids</source><year>2008</year><volume>15</volume><issue>4</issue><fpage>421</fpage><lpage>32</lpage></element-citation></ref><ref id="ref31"><label>31</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Calabresi</surname><given-names>L</given-names></name><name><surname>Villa</surname><given-names>B</given-names></name><name><surname>Canavesi</surname><given-names>M</given-names></name><name><surname>Sirtori</surname><given-names>CR</given-names></name><name><surname>James</surname><given-names>RW</given-names></name><name><surname>Bernini</surname><given-names>F</given-names></name><etal/></person-group><article-title>An omega-3 polyunsaturated fatty acid concentrate increases plasma high-density lipoprotein 2 cholesterol and paraoxonase levels in patients with familial combined hyperlipidemia</article-title><source>Metabolism</source><year>2004</year><volume>53</volume><issue>2</issue><fpage>153</fpage><lpage>8</lpage><pub-id pub-id-type="pmid">14767865</pub-id></element-citation></ref><ref id="ref32"><label>32</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Maritim</surname><given-names>AC</given-names></name><name><surname>Sanders</surname><given-names>RA</given-names></name><name><surname>Watkins</surname><given-names>JB</given-names><suffix>III</suffix></name></person-group><article-title>Diabetes, oxidative stress, and antioxidants: a review</article-title><source>J Biochem Mol Toxicol</source><year>2003</year><volume>17</volume><issue>1</issue><fpage>24</fpage><lpage>38</lpage><pub-id pub-id-type="pmid">12616644</pub-id></element-citation></ref><ref id="ref33"><label>33</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chen</surname><given-names>MS</given-names></name><name><surname>Hutchinson</surname><given-names>ML</given-names></name><name><surname>Pecoraro</surname><given-names>RE</given-names></name><name><surname>Lee</surname><given-names>WY</given-names></name><name><surname>Labbe</surname><given-names>RF</given-names></name></person-group><article-title>Hyperglycemia-induced intracellular depletion of ascorbic acid in human mononuclear leukocytes</article-title><source>Diabetes</source><year>1983</year><volume>32</volume><issue>11</issue><fpage>1078</fpage><lpage>81</lpage><pub-id pub-id-type="pmid">6357907</pub-id></element-citation></ref><ref id="ref34"><label>34</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dyer</surname><given-names>RG</given-names></name><name><surname>Stewart</surname><given-names>MW</given-names></name><name><surname>Mitcheson</surname><given-names>J</given-names></name><name><surname>George</surname><given-names>K</given-names></name><name><surname>Alberti</surname><given-names>MM</given-names></name><name><surname>Laker</surname><given-names>MF</given-names></name></person-group><article-title>7-ketocholesterol, a specific indicator of lipoprotein oxidation, and malondialdehyde in non-insulin dependent diabetes and peripheral vascular disease</article-title><source>Clin Chim Acta</source><year>1997</year><volume>260</volume><issue>1</issue><fpage>1</fpage><lpage>13</lpage><pub-id pub-id-type="pmid">9101096</pub-id></element-citation></ref><ref id="ref35"><label>35</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Merzouk</surname><given-names>S</given-names></name><name><surname>Hichami</surname><given-names>A</given-names></name><name><surname>Madani</surname><given-names>S</given-names></name><name><surname>Merzouk</surname><given-names>H</given-names></name><name><surname>Berrouiguet</surname><given-names>AY</given-names></name><name><surname>Prost</surname><given-names>J</given-names></name><etal/></person-group><article-title>Antioxidant status and levels of different vitamins determined by high performance liquid chromatography in diabetic subjects with multiple complications</article-title><source>Gen Physiol Biophys</source><year>2003</year><volume>22</volume><issue>1</issue><fpage>15</fpage><lpage>27</lpage><pub-id pub-id-type="pmid">12870698</pub-id></element-citation></ref><ref id="ref36"><label>36</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Salonen</surname><given-names>JT</given-names></name><name><surname>Nyyssonen</surname><given-names>K</given-names></name><name><surname>Tuomainen</surname><given-names>TP</given-names></name><name><surname>Maenpaa</surname><given-names>PH</given-names></name><name><surname>Korpela</surname><given-names>H</given-names></name><name><surname>Kaplan</surname><given-names>GA</given-names></name><etal/></person-group><article-title>Increased risk of non-insulin dependent diabetes mellitus at low plasma vitamin E concentrations: a four year follow up study in men</article-title><source>BMJ</source><year>1995</year><volume>311</volume><issue>7013</issue><fpage>1124</fpage><lpage>7</lpage><pub-id pub-id-type="pmid">7580706</pub-id></element-citation></ref><ref id="ref37"><label>37</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yamada</surname><given-names>H</given-names></name><name><surname>Yamada</surname><given-names>K</given-names></name><name><surname>Waki</surname><given-names>M</given-names></name><name><surname>Umegaki</surname><given-names>K</given-names></name></person-group><article-title>Lymphocyte and plasma vitamin C levels in type 2 diabetic patients with and without diabetes complications</article-title><source>Diabetes Care</source><year>2004</year><volume>27</volume><issue>10</issue><fpage>2491</fpage><lpage>2</lpage><pub-id pub-id-type="pmid">15451922</pub-id></element-citation></ref><ref id="ref38"><label>38</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sundaram</surname><given-names>RK</given-names></name><name><surname>Bhaskar</surname><given-names>A</given-names></name><name><surname>Vijayalingam</surname><given-names>S</given-names></name><name><surname>Viswanathan</surname><given-names>M</given-names></name><name><surname>Mohan</surname><given-names>R</given-names></name><name><surname>Shanmugasundaram</surname><given-names>KR</given-names></name></person-group><article-title>Antioxidant status and lipid peroxidation in type II diabetes mellitus with and without complications</article-title><source>Clin Sci (Lond)</source><year>1996</year><volume>90</volume><issue>4</issue><fpage>255</fpage><lpage>60</lpage><pub-id pub-id-type="pmid">8777831</pub-id></element-citation></ref><ref id="ref39"><label>39</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Basu</surname><given-names>TK</given-names></name><name><surname>Tze</surname><given-names>WJ</given-names></name><name><surname>Leichter</surname><given-names>J</given-names></name></person-group><article-title>Serum vitamin A and retinol-binding protein in patients with insulin-dependent diabetes mellitus</article-title><source>Am J Clin Nutr</source><year>1989</year><volume>50</volume><issue>2</issue><fpage>329</fpage><lpage>31</lpage><pub-id pub-id-type="pmid">2756919</pub-id></element-citation></ref><ref id="ref40"><label>40</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhou</surname><given-names>D</given-names></name><name><surname>Ghebremeskel</surname><given-names>K</given-names></name><name><surname>Crawford</surname><given-names>MA</given-names></name><name><surname>Reifen</surname><given-names>R</given-names></name></person-group><article-title>Vitamin A deficiency enhances docosahexaenoic and osbond acids in liver of rats fed an alpha linolenic acid-adequate diet</article-title><source>Lipids</source><year>2006</year><volume>41</volume><issue>3</issue><fpage>213</fpage><lpage>9</lpage><pub-id pub-id-type="pmid">16711595</pub-id></element-citation></ref><ref id="ref41"><label>41</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhou</surname><given-names>D</given-names></name><name><surname>Zaiger</surname><given-names>G</given-names></name><name><surname>Ghebremeskel</surname><given-names>K</given-names></name><name><surname>Crawford</surname><given-names>MA</given-names></name><name><surname>Reifen</surname><given-names>R</given-names></name></person-group><article-title>Vitamin A deficiency reduces liver and colon docosahexaenoic acid levels in rats fed high linoleic and low alpha-linolenic acid diet</article-title><source>Prostaglandins Leukot Essent Fatty Acids</source><year>2004</year><volume>71</volume><issue>6</issue><fpage>383</fpage><lpage>9</lpage><pub-id pub-id-type="pmid">15519497</pub-id></element-citation></ref></ref-list></back></article>